Board of Directors

Daotian Fu

Chair of ChAbS Board of Directors,

Management,
ImmuLogic Ltd

Mitchell Ho

Editor-in-Chief, Antibody Therapeutics;
Chair, ChAbS Advisory Board;
ChAbS Founding Board Member

Senior Investigator and Deputy Chief
of the Laboratory of Molecular Biology
& Director of the Antibody Engineering Program at NCI, NIH

Fubao Wang

ChAbS Founding Board Member

Chief Regulatory Officer & Chief Technical Officer
Medera/ Sardocor

Jingsong Wang

ChAbS Board Member

Founder, Board Chair & CEO,
Harbour BioMed;
Chairman,
Nona Biosciences

Shouye Wang

Founder, Inaugural President of ChAbS

Senior Director,
WuXi XDC

Advisory Board

Mitchell Ho (Chair)

National Cancer Institute, NIH

Chuan-Chu Chou

Free-lance Consultant

Ningning Ma

Shenyang Pharmaceutical University

Lianshan Zhang

Jiangsu Hengrui Medicine

Zhiqiang An

U. of Texas Health Science Center

Yang-Xin Fu

Tsinghua University

David Shen

Propeller Bio

Yanfeng Zhang

AlaMab Therapeutic

Chris Chen

Wuxi Biologics

Audrey Jia

DataRevive LLC

Lin Sun-Hoffman

Liu, Zheng, Chen & Hoffman LLP

Zhenping Zhu

Helixon

Yan Chen

Elpis Biopharmaceutics

Bo Liu

Umabs Therapeutics

Zhidan Tu

RVAC Medicines

Kerry A. Chester

University College London

Shan Lu

U of Massachusetts Medical School

Chenbin Wu

EpimAb Biotherapeutics

Executive Committee

Hongwei Han

Hong Pan

Wei Jia

Yufang Shao

President-elect

You Li

Zheng Xiao

Peng Lin

President

Cong Yao

General Manager

Guangbo Liu

Ning Zhang

Global Volunteers